UK: Kester Capital backs MBO of MAP

Kester Capital, a UK-based lower mid-market private equity specialist, has invested in MAP Patient Access, a market access consulting service to the pharmaceutical and biotech sectors. MAP endeavours to accelerate patient access to medicines, devices, and diagnostics. It has a track record of helping customers navigate increasingly complex healthcare reimbursement pathways, with particular expertise in…

You must be a HMI Subscriber to view this content.

Subscribe Now »